P3 Health Partners Posts $30.8M Q3 Net Income, Lifts FY26 Adjusted EBITDA Midpoint to $100M
PIII has more than doubled off its 52-week low of $1.52.
Summary
P3 Health Partners reported Q3 revenue of $396 million and net income of $30.8 million, and raised the low end of its 2026 Adjusted EBITDA guidance to $90 million, lifting the midpoint to $100 million.
Key Events · Earnings and Guidance · PIII
-
Q3 Profit Swing
Net income of $30.8 million versus a $69.5 million net loss in the prior-year quarter, on total revenue of $396 million, up 15% year over year.
-
Guidance Midpoint Raised
Full-year 2026 Adjusted EBITDA is now guided to a $90 million to $110 million range, a $100 million midpoint, with the low end raised from prior guidance.
-
Margin Boost Is Partly One-Off
Medical margin of $43.9 million ($140 PMPM) included favorable payer settlements and prior-year development; excluding those items it was $35.0 million ($111 PMPM).
-
Cash Position Improves
Cash stood at $43.9 million at September 30, 2026 versus $25.0 million at December 31, 2025, after the preferred stock and warrant financing.
Analysis · PIII · Industrial Applications And Services
The headline swing is stark: a $69.5 million net loss a year ago became $30.8 million of net income on $396 million of revenue, and management raised the low end of full-year Adjusted EBITDA guidance to $90 million, lifting the midpoint to $100 million. Quality is the catch. Medical margin of $43.9 million included favorable payer settlements and prior-year development; strip those out and it was $35.0 million. A going-concern risk factor and a large preferred/warrant overhang from the September financing also remain, so the profit is real but the capital structure still dominates the equity story.
How filings like this one have moved
In the 30 days to Nov 10, 2026, 36.4% of the 3168 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, PIII was trading at $4.25 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $31.3M. The 52-week trading range was $1.52 to $16.89. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.